Cargando…

Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers

BACKGROUND: Although Korea and Japan have a national gastric cancer screening program, their screening intervals are different. The optimal screening interval of endoscopic screening in Japan was investigated based on the stage distributions of screen-detected gastric cancers. METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamashima, Chisato, Narisawa, Rintaro, Ogoshi, Kazuei, Kato, Toshiyuki, Fujita, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680820/
https://www.ncbi.nlm.nih.gov/pubmed/29121881
http://dx.doi.org/10.1186/s12885-017-3710-x
_version_ 1783277834157948928
author Hamashima, Chisato
Narisawa, Rintaro
Ogoshi, Kazuei
Kato, Toshiyuki
Fujita, Kazutaka
author_facet Hamashima, Chisato
Narisawa, Rintaro
Ogoshi, Kazuei
Kato, Toshiyuki
Fujita, Kazutaka
author_sort Hamashima, Chisato
collection PubMed
description BACKGROUND: Although Korea and Japan have a national gastric cancer screening program, their screening intervals are different. The optimal screening interval of endoscopic screening in Japan was investigated based on the stage distributions of screen-detected gastric cancers. METHODS: Patients with gastric cancer detected by endoscopic and radiographic screenings were selected from the Niigata City Medical Association database. The stage distributions of the detected gastric cancers were compared among patients with different screening histories in both groups. Gastric cancer specific survival rates were analyzed using the Kaplan-Meier method with the log-rank test. RESULTS: There were 1585 and 462 subjects in the endoscopic and radiographic screening groups, respectively. In the endoscopic screening group, the stage IV proportion was lower in patients with screening history 1 and 2 years before diagnosis than in patients without screening history. Stage IV development was significantly related to the absence of screening history (p < 0.001); however, there were no differences between patients who had endoscopic screening history 2 and 3 years before diagnosis. The survival rates were not significantly different between patients with endoscopic screening 1 and 2 years previously (p = 0.7763). The survival rates were significantly higher in patients with endoscopic screening history 1 and 2 years before diagnosis than in patients without screening history (p < 0.001), and in patients with endoscopic screaming 3 years before diagnosis (P < 0.0069). CONCLUSION: The endoscopic screening interval for gastric cancer can be expanded to at least 2 years based on the stage distributions of detected cancers and the patient survival rates.
format Online
Article
Text
id pubmed-5680820
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56808202017-11-17 Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers Hamashima, Chisato Narisawa, Rintaro Ogoshi, Kazuei Kato, Toshiyuki Fujita, Kazutaka BMC Cancer Research Article BACKGROUND: Although Korea and Japan have a national gastric cancer screening program, their screening intervals are different. The optimal screening interval of endoscopic screening in Japan was investigated based on the stage distributions of screen-detected gastric cancers. METHODS: Patients with gastric cancer detected by endoscopic and radiographic screenings were selected from the Niigata City Medical Association database. The stage distributions of the detected gastric cancers were compared among patients with different screening histories in both groups. Gastric cancer specific survival rates were analyzed using the Kaplan-Meier method with the log-rank test. RESULTS: There were 1585 and 462 subjects in the endoscopic and radiographic screening groups, respectively. In the endoscopic screening group, the stage IV proportion was lower in patients with screening history 1 and 2 years before diagnosis than in patients without screening history. Stage IV development was significantly related to the absence of screening history (p < 0.001); however, there were no differences between patients who had endoscopic screening history 2 and 3 years before diagnosis. The survival rates were not significantly different between patients with endoscopic screening 1 and 2 years previously (p = 0.7763). The survival rates were significantly higher in patients with endoscopic screening history 1 and 2 years before diagnosis than in patients without screening history (p < 0.001), and in patients with endoscopic screaming 3 years before diagnosis (P < 0.0069). CONCLUSION: The endoscopic screening interval for gastric cancer can be expanded to at least 2 years based on the stage distributions of detected cancers and the patient survival rates. BioMed Central 2017-11-09 /pmc/articles/PMC5680820/ /pubmed/29121881 http://dx.doi.org/10.1186/s12885-017-3710-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hamashima, Chisato
Narisawa, Rintaro
Ogoshi, Kazuei
Kato, Toshiyuki
Fujita, Kazutaka
Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title_full Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title_fullStr Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title_full_unstemmed Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title_short Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
title_sort optimal interval of endoscopic screening based on stage distributions of detected gastric cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680820/
https://www.ncbi.nlm.nih.gov/pubmed/29121881
http://dx.doi.org/10.1186/s12885-017-3710-x
work_keys_str_mv AT hamashimachisato optimalintervalofendoscopicscreeningbasedonstagedistributionsofdetectedgastriccancers
AT narisawarintaro optimalintervalofendoscopicscreeningbasedonstagedistributionsofdetectedgastriccancers
AT ogoshikazuei optimalintervalofendoscopicscreeningbasedonstagedistributionsofdetectedgastriccancers
AT katotoshiyuki optimalintervalofendoscopicscreeningbasedonstagedistributionsofdetectedgastriccancers
AT fujitakazutaka optimalintervalofendoscopicscreeningbasedonstagedistributionsofdetectedgastriccancers